GLP-1 drugs may confound PET/CT imaging findings

GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, according to research presented at the annual meeting of the European Association of Nuclear Medicine (EANM) being held in Barcelona, Spain.

These drugs are now…

Continue Reading